abstract |
The present invention provides a therapeutic method for treating diabetic kidney disease, eg, diabetic nephropathy, comprising administering an effective amount of an A 2A adenosine receptor agonist. If desired, the methods of the invention comprise the administration of a type IV PDE inhibitor. |